The investigators aim to characterize patients presenting with a severe ventricular tachycardia (VT) and premature ventricular complex (PVC)-ablation-related complication including patient characteristics, procedural details and subsequent management of the complication by gathering existing patient-level data.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Centers : Centers participating in the present collaborative study group. Invitation to participate will be based either upon personal referral of one of the investigator, previous collaboration or based on a meta-analytic review of the literature published on the subject within the past 20 years.
* Patients: Females and males of \>18 years undergoing any type of VT/PVC ablation. While we will accept redo-procedure we will ask for a unique patient-identifier to link procedures belonging to the same patients together.
* Interventions: VT/PVC ablation (first intervention or re-do) as routinely performed by the participating centers
* Outcomes: Severe complications, defined as hemodynamic instability requiring mechanical intensive-care management, tamponade, stroke, cardiac arrest, myocardial infarction, phrenic nerve palsies, major bleeding requiring transfusion, vascular or cardiac complication requiring surgery, procedure-related death.
* Setting: Observational cohort studies, registries, retrospective cohort studies. Data stemming from RCTs (Randomized controlled trials) will not be collected as they likely do not represent a "real-life" setting.
* Length of follow-up: Peri-procedural complications
* Years considered: Not limited to a specific time-frame, but to reflect common ablation practices, we will focus on data from the 20 past years.
* Number of patients provided : No lower limit of patients provided per dataset or ablation volume per year to include high- as well as low-volume centers
Exclusion Criteria:
* Refusal of the center to participate.
* Less than 10 procedures available in the dataset (no case reports)
* Missing essential baseline characteristics, missing collection of sufficient details regarding each complication.
Primary outcome measure(s)
Descriptive characterization of patients — up to 30 days characterizing features:
* hemodynamic instability requiring mechanical intensive-care management
* tamponade
* stroke
* cardiac arrest
* myocardial infarction
* coronary artery dissection
* phrenic nerve palsy
* major bleeding as per the International Society on Thrombosis and Haemostasis (ISTH)
* vascular or cardiac complication requiring surgery or interventional management (interventional radiology, angiology)
* iatrogenic atrio-ventricular block requiring device implantation or upgrade.
* procedure-related death
Trial sites (25)
Facility
City
Region
Status
Rush University Medical Center
Chicago
Illinois
Recruiting
University of Michigan
Michigan Center
Michigan
Recruiting
Medical University of Graz
Graz
Austria
Recruiting
Université Laval
Québec
Canada
Recruiting
The First Affiliated Hospital of Nanjing Medical University
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.